Merus NV (MRUS)
44.03
-0.99
(-2.20%)
USD |
NASDAQ |
May 17, 16:00
44.03
0.00 (0.00%)
After-Hours: 20:00
Merus Cash from Financing (TTM): 260.02M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 260.02M |
| December 31, 2023 | 230.09M |
| September 30, 2023 | 228.37M |
| June 30, 2023 | 75.84M |
| March 31, 2023 | 58.08M |
| December 31, 2022 | 58.74M |
| September 30, 2022 | 186.00M |
| June 30, 2022 | 178.72M |
| March 31, 2022 | 132.38M |
| December 31, 2021 | 281.96M |
| September 30, 2021 | 193.68M |
| June 30, 2021 | 191.11M |
| March 31, 2021 | 189.54M |
| December 31, 2020 | 39.52M |
| September 30, 2020 | 74.94M |
| June 30, 2020 | 74.93M |
| March 31, 2020 | 74.64M |
| Date | Value |
|---|---|
| December 31, 2019 | 74.23M |
| September 30, 2019 | 10.29M |
| June 30, 2019 | 11.36M |
| March 31, 2019 | 7.864M |
| December 31, 2018 | 63.04M |
| September 30, 2018 | 57.41M |
| June 30, 2018 | 61.98M |
| March 31, 2018 | 80.20M |
| December 31, 2017 | 223.41M |
| September 30, 2017 | 214.97M |
| June 30, 2017 | 209.53M |
| March 31, 2017 | 251.21M |
| December 31, 2016 | 52.80M |
| September 30, 2016 | 55.40M |
| June 30, 2016 | 101.35M |
| March 31, 2016 | 54.06M |
| December 31, 2015 | 59.44M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
10.29M
Minimum
Sep 2019
281.96M
Maximum
Dec 2021
131.22M
Average
104.11M
Median
Cash from Financing (TTM) Benchmarks
| uniQure NV | 362.59M |
| ProQR Therapeutics NV | -2.640M |
| argenx SE | -- |
| Pharming Group | -0.88M |
| Pharvaris NV | 353.20M |